Le Lézard
Classified in: Health
Subjects: PDT, SBS, MAT

World Hemp Oil and National Farma Announce Breakthrough in Water Soluble CBD Technology


BEAUMONT, Texas, April 22, 2019 /PRNewswire/ -- World Hemp Oil, a leader in the manufacturing and distribution of CBD oil, as well as creating custom CBD formulations for CBD product wholesalers and retailers, announces an alliance with National Farma, a Texas company who recently announced a major breakthrough in their proprietary water soluble CBD technology. World Hemp Oil will be a distributor of National Farma's water soluble CBD to product manufacturers, as well as bulk products featuring National Farma's water soluble CBD to retailers and wholesalers.

National Farma has taken water soluble CBD to the next level by creating the highest quality bioavailable CBD in the industry.  Using their proprietary SonoShear technology and emulsification formula, National Farma has created CBD nano-emulsions with oil droplet sizes under 50 nanometers. This allows for up to 10 times more absorption of the beneficial properties of CBD into the body. This advanced engineered water soluble CBD is odorless and tasteless making it an ideal choice as an additive in all products, including clear beverages.

Bioavailability describes the percentage and rate at which a substance is absorbed into the bloodstream. Oil-water emulsions of nutraceuticals and supplements present a serious challenge for many oral and transdermal therapies, due to most of the beneficial molecules remaining hidden inside of the oil drops. For CBD products commonly consumed orally, including CBD oils in edibles and beverages, absorption is typically below 10%. National Farma believes that processing CBD oil with its proprietary SonoShear technology will deliver greatly improved absorption results (90% or higher) for CBD supplements.

Christopher Cain, of World Hemp Oil, states, "This is a game-changer for the CBD products industry.  CBD products including tinctures, gel caps, creams and topicals, beverages, and edibles will greatly benefit from National Farma's proprietary water soluble CBD technology. CBD products will become highly effective and cost efficient."

Now that the 2018 Farm Bill takes the legal grey area out of retail sales of America, the industry is predicted to explode as major mainstream retailers began to include CBD products on the shelf.  According to data compiled by Brightfield Group, the U.S. hemp CBD market is expected to reach USD 22 Billion by 2022, outpacing the rest of the cannabis market combined.

World Hemp Oil also announces its transition from refining CBD from hemp imported from Europe to sourcing CBD-rich hemp from American farmers. Since the passing of the Federal 2018 Farm Bill, farmers nationwide will be able to grow hemp. American grown hemp is no longer classified as a Schedule 1 drug, therefore allowing retailers and wholesalers to distribute products made with hemp oil produced in America.

About National Farma
"From Farm to Formulations"
National Farma is an American company specializing in the production and distribution of all natural health and wellness nutraceuticals sourced from ingredients straight from the farm.  The company is focused on the fast growing hemp industry and optimizing everything the plant has to offer. National Farma is a leader in the refinement of CBD oil and the formulation of all natural CBD oil products. It provides consulting services regarding new development and custom formulations.

About World Hemp Oil
World Hemp Oil is an American company that was established in 2014. It has become a leader in the manufacturing and refinement of quality CBD oil. The company offers a wide range of CBD oils from raw full spectrum and refined distillate to high quality water soluble CBD oil. It also provides bulk CBD oils and products to wholesalers and retailers.

The statements made regarding CBD oil and CBD products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from healthcare practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.

For all World Hemp Oil inquiries, contact:
Christopher Cain
[email protected] 
512-766-4CBD
WorldHempOil.com

For all National Farma inquiries, contact:
[email protected]
www.nationalfarma.com 

SOURCE World Hemp Oil


These press releases may also interest you

at 05:45
The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to  ResearchAndMarkets.com's offering. Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution...

at 05:10
Neurology Devices: Global Markets is basically a detailed study or report about the worldwide market for medical tools used in treating neurological conditions. These devices could be anything from equipment that helps stimulate the nervous system to...

at 05:04
Sirnaomics Ltd. (the "Company"; together with its subsidiaries, "Sirnaomics" or the "Group"; stock code: 2257), a leading biopharmaceutical company engaged in the discovery and development of advanced RNAi therapeutics, has announced its audited...

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...



News published on and distributed by: